Clinical Validation of <i>PBRM1</i> Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell CarcinomaDavid A. Braun, Toni K. Choueiri, Alice M. Walsh et al.|JAMA Oncology|2019Cited by 242
Regulation of Cell Signaling by Mig6 and Sprouty2 in Cancers With Egfr MutationsAlice M. Walsh|ScholarlyCommons (University of Pennsylvania)|2014Cited by 0